Announcements
We are currently in the process of updating several documents on our website. If you need immediate access to a specific document, please contact the KASPER Help Desk at ekasperhelp@ky.gov.
The KASPER Quarterly Trend Report Review meeting will take place on Tuesday, March 3rd from 1 pm – 2 pm (EST). The link to join is:
Join the meeting now
This meeting will focus on reviewing the KASPER Trend Reports currently published on a quarterly basis. Under KRS 218A.240(7), agencies are responsible for developing the criteria used for these reports. Our office has received funding to enhance the KASPER website and transition trend reports to more interactive formats, consistent with best practices used by other states, such as the Oregon Health Authority. As the trend reports were established several years ago, we are seeking input on data elements and measures to guide future updates.
Effective August 19, 2025, Bromazolam products became Schedule I controlled substances in Kentucky. All applicable provisions of KRS Chapter 218A and 902 KAR Chapter 55 apply. For more information, view the
Bromazolam Fact Sheet.
The go-live date for Narcotic Treatment Program (NTP) data transmission to Kentucky’s Prescription Drug Monitoring Program, KASPER, is scheduled for July 1, 2025.
To aid providers and pharmacists in supporting patients in recovery and understanding the NTP prescription data, a training, “Bridging Data and Recovery” was developed in partnership with the Department of Behavioral Health, Narcotics Treatment Program Providers, Office of Inspector General Pharmacist Consultant and KASPER Program Administrator. This training is available now for Continuing Education credit. We are excited to support individuals struggling with addiction seeking treatment through Medication for Opioid Use Disorder (MOUD). We encourage all providers to attend this training: CECentral "Bridging Data and Recovery" Presentation
If you have any questions or would like more information, please feel free to reach out to Misty Rose, KASPER Program Administrator, mrose@ky.gov 502-564-2815.
The Prescriber FAQ link for KASPER reports that include NTP patient data is:
NTP Prescriber FAQ
The
next Controlled Substance Prescribing Council Meeting will take place on Monday, April 13th, 2026from 3:30 pm - 5:00 pm. Please direct any questions to Misty Rose, KASPER Progam Administrator.
Contact Information is: mrose@ky.gov, Ph. 502-564-7363
The 2025 LRC Report is now available. Access the report here.
We are excited to announce that the KASPER Overview Training is now available on CE Central. This online independent study webinar offers 1 CE credit. Access the training here!
KASPER Update and General Overview
The CDC Prescribing Updates independent study webinar is now available on CE Central. This course offers continuing education (CE) credit, and you can find full credit details on the CE Central website. Access the webinar here.
CDC Prescribing Updates
For technical issues or support for the use of the KASPER system, contact the KASPER Help Desk:
Phone:
(502) 564-2703
Email: KASPER Help Desk
EPCS Mandate
KRS 218A.182 took effect Jan. 1, 2021 and mandates electronic prescribing of controlled substances (EPCS) in Kentucky. A practitioner who is unable to comply with the
EPCS mandate may request a waiver by submitting an
EPCS Temporary Exemption Request Form /EPCS Form (pdf) to CHFS. Although initial waivers were due by Nov. 1, 2020, the Cabinet still is accepting Temporary Exemption Forms. Please send forms by mail to Drug Enforcement and Professional Practices Branch at the address shown on the form or by
email to KASPER.
Integration
KASPER offers integration with account holders' electronic health record or pharmacy management systems. Integration provides fast, reliable and simplified access to KASPER information within the practitioners' or pharmacists' existing workflow. For additional information about the integration process and requirements, please email the
KASPER Integration Team.